05-11-2020
Michael Vi / Shutterstock.com
Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Abbott, COVID-19, US District Court for the Northern District of Illinois, Bio-Rad Laboratories, trade secrets
Oakwood convinces third circuit to reopen TS suit
10-06-2021
Senator calls on Biden to reject COVID IP waiver
02-03-2021
Abbott must face HIV testing patent suit, rules judge
04-12-2020
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13-11-2020
Abbott sues ex-employee over COVID-19 tests
21-10-2020
Abbott agrees to divest two medical device businesses
03-01-2017
